文献速递湿疹皮炎与荨麻疹银屑病与炎症性皮肤病

特应性皮炎患者静脉血栓栓塞风险低于其他免疫介导炎症性疾病

Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
PubMed 文献 · J Am Acad Dermatol · 2023-12-24

该回顾性观察性比较队列研究利用美国Optum Clinformatics理赔数据(2010-2019年),纳入成人特应性皮炎(AD)及其他免疫介导炎症性疾病(IMIDs)患者,并与AD患者1:1匹配的无AD对照比较。结果显示AD患者VTE发生率高于匹配对照(0.73 vs 0.59例/100人年),但控制基线VTE危险因素后AD与VTE风险增加无关(HR 0.96 [0.90-1.02])。AD患者VTE风险低于类风湿关节炎、溃疡性结肠炎、克罗恩病、强直性脊柱炎或银屑病关节炎患者,与银屑病患者相似。

要点

  • AD患者VTE粗发生率高于匹配无AD对照,但校正基线危险因素后无显著增加。
  • AD患者VTE风险低于RA、UC、CD、AS或PsA患者,与PsO患者相似。
  • 研究未考虑疾病活动度和严重程度,解读结果需谨慎。

核心结论

  • 校正基线VTE危险因素后,AD与VTE风险增加无关(HR 0.96 [0.90-1.02])。
  • AD患者VTE风险低于RA、UC、CD、AS或PsA患者,与PsO患者相似。

研究设计与样本

  • 回顾性、观察性、比较队列研究,使用美国Optum Clinformatics理赔数据(2010-2019年)。
  • 纳入成人AD、RA、CD、UC、PsO、PsA或AS患者,无AD对照与AD患者1:1匹配。
  • 共纳入2,061,222例IMIDs患者,其中1,098,633例为AD。

主要发现

  • AD患者VTE发生率为0.73(95% CI 0.72-0.74)例/100人年,高于匹配无AD对照的0.59(95% CI 0.58-0.60)例/100人年。
  • 校正基线VTE危险因素后,AD与VTE风险无关(HR 0.96 [0.90-1.02])。
  • AD患者VTE风险低于RA、UC、CD、AS或PsA患者,与PsO患者相似。

临床怎么用

  • 临床评估AD患者VTE风险时,应关注基线危险因素而非仅AD诊断本身。
  • 与其他IMIDs相比,AD患者的VTE风险相对较低,可据此进行风险分层。

局限性

  • 研究未考虑疾病活动度和严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Certain immune-mediated inflammatory diseases (IMIDs) may increase patients' risk for venous thromboembolisms (VTEs), yet how atopic dermatitis (AD) influences VTE risk remains unclear. OBJECTIVE: Describe VTE incidence in patients with AD compared with other IMIDs and unaffected, AD-matched controls. METHODS: This retrospective, observational, comparative cohort study used Optum Clinformatics United States claims data (2010-2019) of adults with AD, rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), psoriasis (PsO), psoriatic arthritis (PsA), or ankylosing spondylitis (AS). Unaffected control patients were matched 1:1 with patients with AD. RESULTS: Of 2,061,222 patients with IMIDs, 1,098,633 had AD. Patients with AD had a higher VTE incidence (95% CI) than did unaffected, AD-matched controls (0.73 [0.72-0.74] versus 0.59 [0.58-0.60] cases/100 person-years). When controlling for baseline VTE risk factors, however, AD was not associated with increased VTE risk (HR 0.96 [0.90-1.02]). VTE risk was lower in patients with AD versus RA, UC, CD, AS, or PsA; VTE risk was similar to patients with PsO. LIMITATIONS: Disease activity and severity were not accounted for. CONCLUSION: AD did not increase VTE risk when accounting for underlying risk factors. AD was associated with lower VTE risk compared with several rheumatologic and gastrointestinal IMIDs.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Merola JF, Ertmer B, Liang H, et al. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data. J Am Acad Dermatol. 2023. PMID: 38147900. doi:10.1016/j.jaad.2023.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。